Shanghai Haohai Biological Technology Co., Ltd. (6826-HK) Stock Split, History Data
Working capital analysis
In terms of working capital, Shanghai Haohai Biological Technology Co., Ltd. maintains a healthy position.
The total current assets of the company are valued at $3750144000.
This represents a growth rate of 6.173% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $2739999000, exhibiting a growth rate of 7.801% year-on-year.
The receivables, another significant portion of the current assets, are valued at $447650000.
The year-on-year growth rate for receivables is -4.979%.
The inventory, which forms a critical part of the assets, is valued at $526174000.
This represents a healthy year-on-year growth of 8.436%
On the liabilities side, the company's current liabilities total $715951000.
This reflects a growth rate of 40.032% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
2740.00
2541.72
2900.79
3092.60
3222.51
1438.41
Receavebles
447.65
471.11
375.21
340.75
390.00
81.28
Inventory
526.17
485.24
354.76
255.13
239.99
197.63
Other
25.24
34.05
69.65
116.83
76.38
576.57
Total Current Assets
3750.14
3532.12
3712.59
3809.96
3945.38
2293.89
Acc Payable
55.11
54.53
46.26
28.03
36.79
41.18
Short Term Debt
216.63
34.38
66.02
87.71
25.71
20.27
Other Current Liab
444.22
422.36
374.99
318.02
297.47
389.87
Current Liabilities
715.95
511.27
487.27
433.76
359.97
451.32
Capital Structure
When examining the capital structure of Shanghai Haohai Biological Technology Co., Ltd., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Shanghai Haohai Biological Technology Co., Ltd. has chosen to reinvest in the business rather than distribute as dividends.
